SHEFFIELD, United Kingdom, Jan. 8, 2025 /PRNewswire/ — BlackfinBio Ltd (BFB) a clinical stage gene therapy company focused on the development of treatments for rare neurological diseases has announced today that it has acquired the Parkinson’s patent portfolio from OXB. BlackfinBio Ltd…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.